Here we test early validation of the DEspR+CD11b+/CD66b+ neutrophil-subset as a potential therapeutic target for ARDS in different LPS-induced acute inflammation/injury models in three species: humans, rhesus macaques, and rats. Here, ITGAM is linked to acute respiratory distress syndrome.